|
⚲
|
| Keyboard |
| Mahaney Paige
✚
|
|
|---|---|
| CIK # | 0002040313 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002040313] | |
| 4 | [0002040313] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mahaney Paige | |
| C4 Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Tax withheld | 2,446 | $1.89 | 4,623 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Option exercise | 7,050 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Grant | 240,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-10-28 | Option exercise | 19,200 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-10-28 | Tax withheld | 5,644 | $2.58 | 14,562 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Grant | 28,200 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 42,400 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-10-28 | Grant | 76,800 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-10-28 | Grant | 345,600 | $0.00 |